Home
Live Updates
DP Technology Announces Nomination of Development Candidate, a Potential Best-in-Class Kv1.3 Inhibitor for Immunological Diseases Including IBD and AD : comparemela.com
DP Technology Announces Nomination of Development Candidate, a Potential Best-in-Class Kv1.3 Inhibitor for Immunological Diseases Including IBD and AD
/PRNewswire/ -- DP Technology, an "AI for Science" new paradigm-driven company, today announced the nomination of DPT0218, a novel small molecule targeting Kv1....
Related Keywords
Beijing ,
China ,
Xiaomin Zhang ,
Anna Lena Unterweger ,
Fabrizio Giordanetto ,
Johnt Chang ,
Eli Lilly ,
Weijie Sun ,
Prnewswire Dp Technology ,
Company Lilly ,
Dp Technology ,
De Shaw Research ,
Source Dp Technology ,
Inflammatory Bowel Disease ,
Atopic Dermatitis ,
Shaw Research ,
Drug Discovery ,
Reinforced Dynamics ,
Artificial Intelligence ,
Molecular Simulation ,
Exp Med ,
Englj Med ,
Inflammatory Bowel ,
Lena Unterweger ,
Channel Activity ,
Humanised Mouse Model ,
comparemela.com © 2020. All Rights Reserved.